USPTO serial 79015568
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson St. NW, Suite 400Washington, DC 20007UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science [ chemical preparations for use in agriculture, namely, chemical preparations for the treatment of seeds; and chemical preparations for use in photography, namely, chemical developers, unprocessed artificial resins as raw materials in the form of powders, liquids or pastes, unprocessed plastics for industrial use, unprocessed plastics in all forms; manures; fire extinguishing compositions; tempering chemicals for use in metalworking or soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather, adhesives for general industrial use ] | SECTION 70 - CANCELLED | — |
| 003 | [ Bleaching preparations for household use, general purpose cleaning, polishing, scouring and abrasive liquids and powders soaps; soaps; perfumery, essential oils for personal use and for use as ingredients in the manufacture of cosmetic preparations, cosmetics, hair lotions; dentifrices ] | SECTION 71 - CANCELLED | — |
| 005 | [ Pharmaceutical anti-allergic preparations and substances, ] Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations namely, anticoagulants, Pharmaceutical preparations namely, antidepressants, Pharmaceutical preparations namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals for the treatment of erectile dysfunction, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; and Veterinary preparations, namely, pain relief medication, veterinary preparations for the treatment of intestinal bacteria, [ Veterinary vaccine for horses, Veterinary vaccines; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, dressings for wounds, burns, surgery; dental impression materials; disinfectants for hygienic purposes; preparations for destroying vermin; fungicides, herbicides ] | SECTION 70 - CANCELLED | — |
| 042 | Scientific and technological services in the nature of research in the field of agrochemicals, pharmaceuticals and bio-chemistry and design services relating thereto; [ industrial analysis and research services; design and development of computer hardware and software; legal services ] | SECTION 70 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 2, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 2, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 13, 2026 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Oct 29, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 7, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 19, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 23, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 12, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 12, 2018 | INPC | INVALIDATION PROCESSED | — |
| Feb 7, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 7, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 7, 2017 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 7, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 13, 2017 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 13, 2016 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Sep 24, 2015 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 24, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 24, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 10, 2015 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 17, 2014 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 11, 2014 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 17, 2014 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 17, 2014 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Feb 24, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 24, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 24, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 24, 2014 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Nov 21, 2013 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 13, 2013 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Sep 13, 2013 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Aug 27, 2013 | 71AF | REGISTERED-SEC.71 FILED | — |
| Aug 27, 2013 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 27, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 21, 2013 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Mar 21, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 25, 2013 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 9, 2009 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Oct 9, 2009 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Oct 9, 2009 | CAND | CANCELLATION DENIED NO. 999999 | — |
| May 4, 2009 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Jun 27, 2008 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 22, 2008 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 18, 2007 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 18, 2007 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 10, 2007 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 13, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 26, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 31, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 13, 2006 | ALIE | ASSIGNED TO LIE | — |
| Oct 6, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2006 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 5, 2006 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 5, 2006 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 19, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 31, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 23, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 22, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 21, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 20, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 20, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2005 | NWAP | NEW APPLICATION ENTERED | — |
| Oct 20, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |